503-222-1261 info@crgpdx.com

Type 2 Diabetes Mellitus

This is a phase 3, randomized, double-blind, placebo-controlled study to evaluate an investigational medication in subjects with type 2 diabetes mellitus who are not adequately controlled by metformin alone. The medication belongs to a class of diabetic medication called SGLT2…

Read More